CoChat

Targeting the CCL2-CCR2 axis in depressive disorders

Open access
Curzytek, Katarzyna, Leśkiewicz, Monika · 2021 · Pharmacological Reports

The DOI matches its Crossref record; the references it cites are not checked yet.

Abstract

Since affective disorders are considered to be underlain by the immune system malfunction, an important role in their pathophysiology is assigned to the proinflammatory mediators. Recently, chemokines, the group of chemotactic cytokines, have become a focus for basic and clinical scientists in the context of the development and treatment of brain diseases. Among them, chemokine CCL2 and its main receptor CCR2 have become candidate mediators of abnormal brain-immune system dialogue in depression. Besides the chemotactic activity, the CCL2-CCR2 axis is involved in various neurobiological processes, neurogenesis, neurotransmission, neuroinflammation, neurodegeneration, as well as neuroregeneration. Given the range of immunomodulatory possibilities that the CCL2-CCR2 pair can exert on the nervous system, its proinflammatory properties were initially thought to be a major contributor to the development of depressive disorders. However, further research suggests that the malfunctions of the nervous system are rather associated with impaired homeostatic properties manifested by the CCL2-CCR2 dyad dysfunctions. This review aims to present literature data on the action of the CCL2-CCR2 axis in the central nervous system under physiological and pathological conditions, as well as the contribution of this ligand-receptor system to the processes underlying affective disorders. Additionally, this article draws attention to the importance of the CCL2-CRR2 pathway as a potential pharmacological target with antidepressant potential.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s43440-021-00280-w

Cites

Statistics

Figures

Fig. 1 CCL2-CCR2 interaction and signaling molecules participating in the regulation of the inflammatory activation state of the brain cells. AC adenylate cyclase, PLC-β phospholipase c-β, PKC protein kinase C, MAPK mitogen-activated protein kinases, ERK extracellular signal-regulated kinase, JAK2 Janus kinase 2, JNK c-jun N-terminal kinase, PI3-K phosphoinositide 3-kinase, CaMKII Ca2+/calmodulin-dependent protein kinase, RhoA cytoplasmatic protein belonging to the family of small GTPases
Fig. 1 CCL2-CCR2 interaction and signaling molecules participating in the regulation of the inflammatory activation state of the brain cells. AC adenylate cyclase, PLC-β phospholipase c-β, PKC protein kinase C, MAPK mitogen-activated protein kinases, ERK extracellular signal-regulated kinase, JAK2 Janus kinase 2, JNK c-jun N-terminal kinase, PI3-K phosphoinositide 3-kinase, CaMKII Ca2+/calmodulin-dependent protein kinase, RhoA cytoplasmatic protein belonging to the family of small GTPasesCC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

The citation lists are queued

They are fetched later and appear here then.

References 85 · Cited by 47

Metadata

Authors
Curzytek, K., & Leśkiewicz, M.
Affiliations
Maj Institute of Pharmacology (PL)
Corresponding author
Curzytek, Katarzyna
Venue
Pharmacological Reports
Published
2021-05-24
Volume
73
Issue
4
Pages
1052-1062
ISSN
  • 1734-1140 (ISSN-L)
  • 2299-5684
OpenAlex
W3165273974
Cited by
47
References
85
Citations by year
2026: 4 · 2025: 11 · 2024: 14 · 2023: 8 · 2022: 9 · 2021: 1
FWCI
0.75
Type
journal article
Language
en
Open access
Licence
Locations
  • Pharmacological Reports (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
Statutory Funds of the Department of Experimental Neuroendocrinology, Maj Institute of Pharmacology
Topics
  • Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Keywords
MCP-1, CCR2, chemokines, depression, depressive disorders, neuroinflammation, pro-inflammatory mediators, antidepressant targets, chemokine receptors, neurogenesis, neurotransmission, nerve regeneration
MeSH terms
Animals, Antidepressive Agents, Central Nervous System, Depressive Disorder, Humans, Signal Transduction, Chemokine CCL2, Receptors, CCR2

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Targeting the CCL2-CCR2 axis in depressive disorders. https://app.cochat.ai/papers/10.1007/s43440-021-00280-w
The paper
Curzytek, K., & Leśkiewicz, M. (2021). Targeting the CCL2-CCR2 axis in depressive disorders. Pharmacological Reports. https://doi.org/10.1007/s43440-021-00280-w

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.